Juying Wei^1*, Wenjuan Yu, MD^2*, Zhengming Jin, B.S.^3*, Keshu Zhou, MD^4*, Haiyan Yang^5*, Fei Li^6*, Lanfang Li^7*, Miao Hu⁸, Xinglu Zhou^8* and Jie Jin⁹

¹Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, PR China;, Hangzhou, China
²First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
³Department of Hematology, Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, the First Affiliated Hospital of Soochow University, Suzhou, China
⁴Department of Hematology, Henan Cancer Hospital, Zhengzhou, China
⁵Department of Hematology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China
⁶Department of Hematology, The First Affiliated Hospital of Nanchang University, Nanchang, China
⁷Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
⁸HealZen Therapeutics Co., Ltd, Hangzhou, China
⁹Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Ryan C Lynch, MD¹, Stefan K. Alig, MD², Chaitra S Ujjani, MD³, Christina Poh, MD⁴, Edus H Warren, MD, PhD³, Stephen D Smith, MD³, Mazyar Shadman, MD, MPH³, Brian G Till³, Vikram Raghunathan, MD^4*, Yolanda D Tseng, MD^5*, Susan Ottemiller^1*, Bonnie Joy^1*, Melissa Mary Fessel, ANP, BSN, RN^1*, Hongyan Du^6*, Jacquelin Vandermeer, BS^3*, Alyssa Kelly^1*, Heather Rasmussen^7*, Jenna M Voutsinas, MPH^8*, Qian Wu^3*, Ash A. Alizadeh, MD, PhD² and Ajay K Gopal, MD⁴

¹Fred Hutch Cancer Center, Seattle, WA
²Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA
³Fred Hutchinson Cancer Center, Seattle, WA
⁴Clinical Research Division, Fred Hutch Cancer Center; and Division of Oncology, University of Washington, Seattle, WA
⁵Department of Radiation Oncology, University of Washington and Fred Hutch Cancer Center, Seattle, WA
⁶University of Washington, Seattle, WA
⁷Division of Hematology and Oncology, University of Washington, Seattle, WA
⁸Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA

Jie Jin¹, Qingqing Cai, PhD^2*, Liling Zhang^3*, Liqun Zou, MD, PhD^4*, Zengjun Li^5*, Huijing Wu^6*, Keshu Zhou, MD^7*, Lihua Qiu^8*, Liping Su^9*, Kaiyang Ding^10*, Hui Zhou¹¹, Li Yu^12*, Fei Li^13*, Qing Xiao^14*, Wenyu Li^15*, Lie Lin, MD^16*, Erhua Wang^17* and Lijia Chen^18*

¹Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, PR China;, Hangzhou, China
²Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China
³Department of Lymphoma, Wuhan Tongji Union Hospital, Wuhan, China
⁴West China Hospital of Sichuan University, Chengdu, China
⁵Department of Lymphoma and Hematology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Ji'nan, Shandong, China
⁶Hubei Cancer Center, Wuhan, CHN
⁷Department of Hematology, Henan Cancer Hospital, Zhengzhou, China
⁸Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
⁹Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Taiyuan, China
¹⁰Department of Hematology, Anhui Provincial Cancer Hospital, Hefei, China
¹¹Hunan Cancer Hospital, Changsha, China
¹²The Second Affiliated Hospital of Nanchang University, Nanchang, China
¹³The First Affiliated Hospital of Nanchang University, Nanchang, China
¹⁴The First Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing, CHN
¹⁵Guangdong Provincial People's Hospital, Guangzhou, China
¹⁶Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, China
¹⁷Department of Hematology, The Third Xiangya Hospital, Central South University, Changsha, CHN
¹⁸Dizal pharma, Shanghai, China

Seda S. Tolu, MD¹, Alexander Sanjurjo², David Destephano, MPH^3*, Barbara Pro, MD⁴ and Jennifer E. Amengual, MD⁵

¹Division of Hematology and Oncology, Columbia University Irving Medical Center, New York City, NY
²Columbia University Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York
³Columbia University Medical Center, New York, NY
⁴Lymphoma Program, Division of Hematology & Oncology, Columbia University, New York, NY
⁵Lymphoma Program, Division of Hematology & Oncology, Columbia University Irving Medical Center, New York

Pier Luigi Zinzani, MD, PhD¹, Franck Morschhauser, MD PhD², Tomas Janik^3*, Nick Manamley^3*, Kasia Hilgier, MD^3* and Anna Maria Sureda Balari, MD, PhD⁴

¹IRCCS Azienda Ospedaliero-Universitaria di Bologna  Istituto di Ematologia “Seràgnoli” and Dipartimento di Scienze Mediche e Chirurgiche,  Università di Bologna, Bologna, Italy
²CHRU de Lille, Hôpital Claude Huriez, Lille, Cedex, FRA
³Mundipharma Research Ltd, Cambridge, United Kingdom
⁴Clinical Hematology, Instituto Catalán de Oncología, L'Hospitalet De Llobregat, IDIBELL, Universitat de Barcelona, Barcelona, Spain

Matthew G. Mei, MD¹, Gaetano Corazzelli^2*, Frank Morschhauser³, Elizabeth Phillips, MD⁴, Graham P. Collins, MBBS, DPhil⁵, Hun Ju Lee, MD^6*, Steve M Ansell⁷, Craig H. Moskowitz, MD⁸, Nathalie A. Johnson, MD, PhD,⁹, John Kuruvilla, MD, FRCPC¹⁰, Martin Hutchings, MD, PhD^11*, María José Terol Castera^12*, George Hawkins^13*, Anna Vossenkaemper^13*, Teresa Collins^13*, Robin Lesley^14*, Emma Dean^13*, Ting Yu^15*, Connor Hall, MD^16*, Virginie Cerec^13* and Pier Luigi Zinzani, MD, PhD¹⁷

¹City of Hope National Medical Center, Duarte, CA
²Department of Hematology & Developmental Therapeutics, National Cancer Institute, Fondazione ‘G. Pascale’, IRCCS, Naples, Campania, ITA
³Hôpital Claudie Huriez, Lille, France
⁴The Christie NHS Foundation Trust and The University of Manchester, Manchester, United Kingdom
⁵Oxford University Hospitals, Oxford, United Kingdom
⁶Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Mayo Clinic, Rochester, MN
⁸Sylvester Comprehensive Cancer Center, University of Miami, Coral Gables, FL
⁹Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada
¹⁰Princess Margaret Cancer Centre, Toronto, ON, Canada
¹¹University Hospital of Copenhagen, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark
¹²Hospital Clínico Universitario INCLIVA, Valencia, ESP
¹³AstraZeneca, Cambridge, United Kingdom
¹⁴AstraZeneca, South San Francisco, CA
¹⁵AstraZeneca, South San Francisco
¹⁶AstraZeneca, Gaithersburg, MD
¹⁷Institute of Hematology "Seràgnoli" University of Bologna, Bologna, Italy

Udomsak Bunworasate^1*, Kitsada Wudhikarn, MD², Thanawat Rattanathammethee, M.D.^3*, Lalita Norasetthada, M.D.³, Pimjai Niparuck, MD^4*, Suporn Chancharunee, MD^4*, Kanchana Chansung, MD^5*, Archrob Khuhapinant, MD, PhD^6*, Peerapon Wong, MD^7*, Pannee Praditsuktavorn, MD^8*, Tontanai Numbenjapon, MD^9*, Jakrawadee Julamanee, MD, PhD¹⁰ and Tanin Intragumtornchai, MD^2*

¹Division of Hematology and Excellence Center in Translational Hematology, Faculty of Medicine, Chulalongkorn University, Bangkok, AL, Thailand
²Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand
³Chiang Mai University, Chiang Mai, Thailand
⁴Mahidol University, Ramathibodi Hospital, Bangkok, Thailand
⁵Khon Kaen University, Khon Kaen, Thailand
⁶Mahidol University, Siriraj Hospital, Bangkok, Thailand
⁷Naresuan University, Phitsanulok, Thailand
⁸Chulabhorn Hospital, Bangkok, Thailand
⁹Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand
¹⁰Prince of Songkla University, Songkhla, Thailand

Christopher Yasenchak, MD¹, Rodolfo Bordoni^2*, Dipti Patel-Donnelly, MD ³, Timothy Larson, MD^4*, Jerome Goldschmidt, MD^5*, Ralph Boccia^6*, Vivian J. M. Cline^7*, Shweta Jain^8*, Jingmin Liu^8* and Joseph Thaddeus Beck, MD^9*

¹Willamette Valley Cancer Institute and Research Center/US Oncology Research, Eugene, OR
²Georgia Cancer Specialists, Marietta, GA
³Virginia Cancer Specialists, Fairfax, VA
⁴Minnesota Oncology P.A, Minneapolis, MN
⁵Oncology and Hematology Associates of SW Virginia, Blacksburg, VA
⁶Center for Cancer and Blood Disorders, Johns Hopkins Medicine, Bethesda, MD
⁷US Oncology, Austin, TX
⁸Seagen Inc., Bothell, WA
⁹Highlands Oncology Group, P.A., Fayetteville, AR

Kelsey Baron, MD¹, Esther Drill, DrPH^2*, Nivetha Ganesan^3*, Reid W. Merryman, MD⁴, Matthew G. Mei, MD⁵, Robert Stuver, MD³, Sanjal H. Desai, MBBS^6,7, Ayo S Falade, MD, MBA⁸, Siddharth Iyengar, MD⁹, Ivana Micallef, MD^7*, Lay She Ng, MD^7*, Ellie Casper^3*, Natasha Galasso^3*, Randa Tao, MD^1*, Savita Dandapani, MD, PhD^5*, Andrea Ng, MD, MPH^4*, Joachim Yahalom, MD¹⁰, Alex F. Herrera, MD¹¹, Alison Moskowitz, MD³ and Harsh Shah, DO^1*

¹Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
²Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
³Memorial Sloan Kettering Cancer Center, New York, NY
⁴Dana-Farber Cancer Institute, Boston, MA
⁵City of Hope National Medical Center, Duarte, CA
⁶University of Minnesota, Saint Paul, MN
⁷Mayo Clinic, Rochester, MN
⁸Mass General Brigham Salem Hospital, Salem, MA
⁹University of Southern California, Los Angeles
¹⁰Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
¹¹City of Hope, Duarte, CA

Justin Ferdinandus, MD^1,2*, Gundolf Schneider, M.Sc.^1,2*, Alexander Fosså, MD^3*, Alden Moccia, MD^4*, Richard Greil, MD⁵, Mark S. Hertzberg, MD⁶, Josée M. Zijlstra, MD, PhD⁷, Peter Kamper, MD, PhD^8*, Daniel L. Molin, MD^9*, Andrea Kerkhoff, MD^10*, Sebastian Scholl, MD^11*, Yon-Dschun Ko, MD^12*, Max S. Topp, MD^13*, Joachim Beck, MD^14*, Vladan Vucinic, M.D.^15*, Wolfram Jung, MD^16*, Roland Schroers, MD^17*, Andreas Rank, MD^18*, Carla Damaschin, MD^1,2*, Anne Sophie Jacob, MD^1,2*, Michael Fuchs, MD^1,2*, Peter Borchmann^1,2 and Karolin Behringer, MD^1,19*

¹German Hodgkin Study Group, Cologne, Germany
²Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany
³Department of Oncology, Oslo University Hospital, Oslo, Norway
⁴Medical Oncology, Oncology Institute of Southern Switzerland, EOC, Locarno, Switzerland
⁵Paracelsus Medical University, Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Salzburg, Austria
⁶Prince of Wales Hospital and University of New South Wales, Sydney, Australia
⁷Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
⁸Department of Hematology, Aarhus University Hospital, Aarhus, Denmark
⁹Oncology Department, Uppsala University, Uppsala, Sweden
¹⁰Medical Department A for Hematology, Oncology, and Pneumology, University Hospital Muenster, Muenster, Germany
¹¹Klinik für Innere Medizin II, Jena University Hospital, Jena, Germany
¹²Department of Internal Medicine, Johanniter Hospital, Bonn, Germany
¹³Department of Internal Medicine II, Hematology and Oncology, University Hospital Wuerzburg, Wuerzburg, Germany
¹⁴Department of Medicine III, Universitätsmedizin Mainz, Mainz, Germany
¹⁵Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University of Leipzig, Leipzig, Germany
¹⁶Department of Haematology and Oncology, Göttingen, Germany
¹⁷Knappschaftskrankenhaus Bochum, University Hospital Bochum, Bochum, Germany, Bochum, Germany
¹⁸Department of Internal Medicine II, University Hospital Augsburg, Augsburg, Germany
¹⁹Department I of Internal Medicine, German Hodgkin Study Group (GHSG), University Hospital of Cologne, Cologne, Germany

Robert Stuver, MD¹, Nivetha Ganesan^1*, Ahmet Dogan, MD, PhD², Zachary D. Epstein-Peterson, MD³, Paola Ghione, MD, MSEpi¹, William Johnson^1*, Natasha Lewis, MD^1*, Alison Moskowitz, MD¹, Gunjan L. Shah¹, Michael Scordo⁴, Wenbin Xiao, MD, PhD² and Steven M. Horwitz, MD¹

¹Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Pathology and Laboratory Medicine, Hematopathology Service, Memorial Sloan Kettering Cancer Center, New York, NY
³Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

David Sibon, MD, PhD^1*, Jean Marc Schiano De Colella, MD^2*, Emmanuel Itti, MD, PhD^3*, Thu-Ha Dao, MD^4*, Lucie Oberic, MD^5*, Romain Ricci^6*, Camille Laurent, MD, PhD^7*, Luc Xerri, MD, PhD^8*, Marc André, MD, PhD^9*, Emmanuelle Nicolas Virelizier, MD^10*, Christophe Bonnet, MD, PhD^11*, Alexandre Karangwa, MD^12*, Luc-Matthieu Fornecker, MD, PhD^13*, Emmanuel Bachy, MD, PhD^14*, Marie Bannier, MD^15*, Alexandra Traverse-Glehen, MD, PhD^16*, Youlia Kirova, MD, PhD^17*, Cyrielle de Lacheisserie^18*, Romain Ould-Ammar^19*, Patrick Fogarty^20*, Nadia Amara^21*, Virginie Fataccioli^22*, Hervé Tilly, MD²³, Lionel Tortolano, PharmD, PhD^24*, Romain Bosc, MD, PhD^25*, Fabien Le Bras, MD^1*, Philippe Gaulard, MD, PhD^22* and Corinne Haioun, MD, PhD¹

¹Lymphoid Malignancies Department, Henri Mondor University Hospital, AP-HP, Créteil, France
²Institut Paoli-Calmettes, Marseille, France
³Nuclear medicine department, Henri Mondor University Hospital, AP-HP, Créteil, FRA
⁴Department of Radiology, Henri Mondor University Hospital, AP-HP, Créteil, France
⁵Hematology Department, IUCT - Oncopole, Toulouse, Toulouse, FRA
⁶LYSA-IM, Henri Mondor University Hospital, AP-HP, LYSARC, Créteil, FRA
⁷Pathology Department, Institut Universitaire du Cancer , Oncopole, Toulouse, France
⁸Pathology Department, Institut Paoli Calmettes, Marseille, FRA
⁹Department of Hematology, Saint-Luc - UCLouvain, Brussels, Belgium
¹⁰Hematology Department, Centre Léon Bérard, Lyon, FRA
¹¹Hematology Department, CHU Liège, Liège, Belgium
¹²Hematology Department, Perpignan Hospital, Perpignan, France
¹³Hematology Department, Institut De Cancérologie Strasbourg Europe, Strasbourg, France
¹⁴Hematology Department, Lyon Sud Hospital, Pierre-Bénite, France
¹⁵Breast surgery department, Institut Paoli-Calmettes, Marseille, FRA
¹⁶Department of Pathology, Lyon Sud Hospital, Pierre Benite, France
¹⁷Radiation Therapy, Institut Curie, Paris, FRA
¹⁸LYSARC, Pierre Bénite, France
¹⁹Statistics Department, LYSARC, Pierre Bénite, France
²⁰Statistics Department, LYSARC, Pierre Bénite, FRA
²¹Pathology Department, Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France
²²Pathology Department, Henri Mondor University Hospital, AP-HP, Créteil, FRA
²³Centre Henri-Becquerel, Rouen, France
²⁴Department of Pharmacy, Henri Mondor University Hospital, AP-HP, Créteil, France
²⁵Plastic and Reconstructive Surgery Department, Hôpital Européen Georges Pompidou, AP-HP, Paris, France

John Timmerman, MD¹, David Lavie^2*, Nathalie A. Johnson, MD, PhD,³, Abraham Avigdor, MD⁴, Peter Borchmann⁵, Charalambos Andreadis, MD⁶, Ali Bazargan, MD⁷, Gareth P. Gregory⁸, Colm Keane, MD⁹, Inna Tzoran, MD^10*, Vladan Vucinic, M.D.^11*, Pier Luigi Zinzani, MD, PhD^12,13, Rachel Marceau West^14*, Pallavi Pillai, MD¹⁴, Patricia Marinello, PharmD¹⁴ and Alex F. Herrera, MD¹⁵

¹UCLA Medical Center, Los Angeles, CA
²Hadassah Medical Center, Jerusalem, Israel
³Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada
⁴Sheba Medical Center–Tel HaShomer, Ramat Gan, Israel
⁵University Hospital Cologne, Cologne, Germany
⁶UCSF, San Francisco, CA
⁷University of Melbourne, Melbourne, St Vincent’s Hospital, Fitzroy, VIC, Australia
⁸School of Clinical Sciences at Monash Health, Monash University, Melbourne, VIC, Australia
⁹Princess Alexandra Hospital, Brisbane, QLD, Australia
¹⁰Rambam Health Care Campus, Haifa, Israel
¹¹Leipzig University Medical Center, Clinic and Policlinic for Hematology, Cell Therapy and Hemostaseology, Leipzig, Germany
¹²Istituto di Ematologia "Seràgnoli", IRCCS Azienda Ospedaliero–Universitaria di Bologna, Bologna, Italy
¹³Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy
¹⁴Merck & Co., Inc., Rahway, NJ
¹⁵City of Hope, Duarte, CA

Sofía Gabriela Rivarola, MD^1*, German R. Stemmelin, MD^2*, Jule F Vasquez, MD³, Maria Elvira Enciso Arrua, MD^4*, Seisha Von Glasenapp, PhD^5*, Carolina Oliver, MD⁶, Fernando Warley, MD^7*, Maria Orlova, MD^7*, Rosa Oliday Rios Jiménez^8*, Alfredo Reinaldo Quiroz, MD^9*, Marialejandra Torres Viera, MD^10,11*, Henry Idrobo Quintero^12,13,14,15*, Diego Fernando Garces Paz, MD^16*, Denisse Castro, MD^17,18,19,20, Julio D Fernández Águila, MD^21*, Victoria Irigoín, MD^22*, Jorge J. Castillo, MD²³, Brady E Beltran, MD^24,25*, Luis Vilela, MD^26*, Bryan Valcarcel, MD, MPH²⁷ and Luis Enrique Malpica Castillo, MD²⁸

¹Hospital Británico de Buenos Aires, CABA, AL, Argentina
²Hospital Britanico BS.AS, Buenos Aires, Caba, ARG
³Oncosalud - AUNA, Lima, Peru
⁴Departamento de Hematología, Hospital Central Instituto de Previsión Social, Asunción, Paraguay
⁵Department of Hematology, INSTITUTO DE PREVISION SOCIAL, Asuncion, Paraguay
⁶British Hospital, Montevideo, Uruguay
⁷Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
⁸Hospital Clínico Quirúrgico Hermanos Amejeiras, La Habana, Cuba
⁹Hospital Central IPS, Asuncion, Paraguay
¹⁰Clinica Santa Sofia, Caracas, Miranda, VEN
¹¹Unidad Linfomas, Instituto Hematología y Oncología Universidad Central Venezuela, Caracas, Venezuela (Bolivarian Republic of)
¹²Universidad del Valle, Cali, Colombia
¹³Centro Médico Julían Coronel, Cali, Colombia
¹⁴Clinica la Estancia, Popayan, Colombia
¹⁵Asociación Colombiana de Hematología y Oncología (ACHO), Bogotá, Colombia
¹⁶Instituto Nacional de Oncología Ospedale INOOS, Bogota, Colombia
¹⁷MAMLAB CENTER, Lima, Peru
¹⁸Hospital Edgardo Rebaglati Martins, lima, Peru
¹⁹Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru
²⁰Centro de Investigación de Medicina de Precisión, Universidad de San Martin de Porres, Lima, Peru
²¹Hospital Universitario Dr Gustavo Aldereguía Lima, Cienfuegos, Cuba
²²Hospital De Clinicas, Montevideo, URY
²³Dana-Farber Cancer Institute, Bing Center for Waldenström Macroglobulinemia, Boston, MA
²⁴Instituto de Investigaciones en Ciencias Biomédicas (INICIB). Universidad Ricardo Palma, Lima-Perú., Lima, Peru
²⁵Servicio Oncología Médica, Hospital Edgardo Rebagliati, Lima, Peru
²⁶Hospital Fernando Ocaranza ISSSTE/ Dr. Ignacio Chávez ISSSTESON. Hermosillo Sonora Universidad Autónoma de Sinaloa., Sinaloa, Mexico
²⁷The George Washington University, Washington, DC
²⁸Department of Lymphoma and Myeloma, University of Texas MD Anderson cancer Center, Houston, TX

Andrew Bruce McDonald, MBBS^1*, Estelle Verburgh, MBChB, M Med Int, FCPSA, PhD², Manuel Gotti^3*, Antonio Pinto, MD^4*, Jan Maciej Zaucha, Prof^5*, Vladimir Ivanov^6*, Vladimir Melnichenko^7*, Heidi Mocikova, MD, PhD^8*, Muhit Ozcan, MD^9*, Caterina Patti, MD^10*, João Farias^11*, Iara Zapparoli Goncalves, MD^12*, Olha Kuchkova^13*, Jiří Mayer, MD¹⁴, Güray Saydam^15*, Sarah Tomassetti^16*, Kumudu Pathiraja^17*, Katherine Elizabeth Ryland, PhD¹⁷, Patricia Marinello, PharmD¹⁷ and Wojciech Jurczak, MD, PhD¹⁸

¹Alberts Cellular Therapy, Netcare Pretoria East Hospital, Pretoria, South Africa
²Department of Medicine, Division of Clinical Haematology, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa
³Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
⁴Hematology-Oncology and Stem Cell Transplantation Unit, Istituto Nazionale Tumori, Fondazione ‘G. Pascale’, IRCCS, Naples, Italy
⁵Department of Haematology and Transplantology, Medical University of Gdańsk, Gdańsk, Poland
⁶Almazov National Medical Research Center, St. Petersburg, Russian Federation
⁷Pirogov National Medical Surgical Center, Moscow, Russian Federation
⁸Department of Clinical Hematology, University Hospital Kralovske Vinohrady, Prague, Czech Republic
⁹Department of Hematology, School of Medicine, Ankara University, Ankara, Turkey
¹⁰Onco-Hematology Unit, Azienda Ospedaliera Riunita Villa Sofia-Vincenzo Cervello, Palermo, Italy
¹¹Hospital Erasto Gaertner, Curitiba, PR, BRA
¹²Fundação Pio XII-Hospital de Câncer de Barretos, São Paulo, Brazil
¹³Kharkiv National Medical University, Kharkiv, Ukraine
¹⁴University Hospital Brno and Masaryk University, Brno, Czech Republic
¹⁵Department of Internal Diseases, Division of Hematology, Ege University Medical Faculty Hospital, Izmir, Turkey
¹⁶Division of Hematology and Oncology, Harbor-UCLA Medical Center, Torrance, CA
¹⁷Merck & Co., Inc., Rahway, NJ
¹⁸Dpt of Clinical Oncology, MSC National Research Institute of Oncology, Kraków, Poland

Lauren M. Fahmy, BS¹, Hye Ryung Yang, MD^2*, Mengxi Zhou, MS^2*, Volkan Beylergil, MD^2*, Celine M. Schreidah^1*, Zaid Bilgrami, MD^2*, Bradley D. Kwinta, MD^1*, Lawrence Schwartz, MD^3*, Antonio T. Fojo, MD, PhD^2*, Susan E. Bates, MD^2* and Larisa J. Geskin, MD^4*

¹Columbia University Vagelos College of Physicians and Surgeons, New York, NY
²Columbia University Irving Medical Center, Columbia University, New York, NY
³Memorial Sloan Kettering Cancer Center, New York, NY
⁴Department of Dermatology, Columbia University Irving Medical Center, New York, NY

Emmanuel Ledoult^1*, Matthieu Groh, MD, MSc^2*, Bertrand Meresse^3*, Romain Dubois^4*, Jacques Trauet^3*, Elise Toussaint^5*, Marie Delbeke^3*, Eric Hachulla^6*, Louis Terriou^7*, Adèle De Masson^8*, Michèle Vasseur^9*, Myriam Labalette^10*, David Launay^11*, Jean-Emmanuel Kahn^12* and Guillaume Lefèvre^13*

¹Internal Medicine and Clinical Immunology, CHU Lille, Lille, France
²French National Reference Center for Hypereosinophilic Syndromes (CEREO), Departement of Internal Medicine, Hôpital Foch, Suresnes, France
³CHU Lille, Lille, France
⁴CHRU De Lille, Lille, FRA
⁵Institut de Cancerologie Strasbourg Europe (ICANS), Strasbourg, FRA
⁶Université De Lille 2, Lille, FRA
⁷Service de Médecine Interne et Immunologie Clinique, CHU Lille, Lille, France
⁸Hôpital Saint-Louis, Paris, FRA
⁹Pharmacology, CHU Lille, Lille, France
¹⁰CHU LILLE, LILLE, FRA
¹¹Hôpital Claude-Huriez, Lille, FRA
¹²CHU Ambroise Paré, Boulogne Billancourt, FRA
¹³Laboratoire d'Immunologie, CHU de Lille, Lille, France

Wenyu Shi, MD, PhD^1,2*, Yi Miao, MD^2,3*, Jing Zhang^2,3* and Jianyong Li, MD^2,3

¹Affiliated Hospital of Nantong University, Nantong, China
²Jiangsu Cooperative Lymphoma Group (JCLG) and Jiangsu Histiocytosis Association Lymphoma Group (JHA-LG), Nanjing, China
³Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China

Richard C. Godby, MD¹, Kari G. Rabe, MS^1*, Steven R. Hwang, MD¹, Hadiyah Audil, MD¹, Susan L. Slager, PhD², Saad S. Kenderian, MD¹, Neil E. Kay, MD³, Yucai Wang, MD, PhD¹, Paul J Hampel, MD¹, Sameer A. Parikh, MD¹, Wei Ding, MD, PhD⁴ and Min Shi, MD, PhD^4*

¹Mayo Clinic, Rochester, MN
²Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
³Department of Immunology, Mayo Clinic, Rochester, MN
⁴Mayo Clinic, Co-Senior Author, Rochester, MN

Min Bai, PhD^1*, Li-Ping Su^2* and Tao Guan^2*

¹Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital/Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, AL, China
²Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital/Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China

Linlin Huang^1*, Hanjin Yang^2*, Yang Yang^3*, Fang Yu^4*, Yi Zhao^5*, Xiujin Ye^6*, Weiyan Zheng, MD^5*, Jie Sun^5*, Enfan Zhang^7*, Zhen Cai, PhD, MD^8* and Jingsong He^9*

¹Bone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang University,, Hangzhou, China, Hangzhou, China
²Department of Pathology, The First Affiliated Hospital, School of Medicine, Zhejiang University, hangzhou, China
³Department of Hematology and Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China, Hangzhou, China
⁴Department of Pathology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Taiwan
⁵Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
⁶Bone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang University, hangzhou, CHN
⁷Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, CHN
⁸Bone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang University, hangzhou, China
⁹The Department of Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Daniela Urueta Portillo, MD^1*, Supreet Kaur, MD², Qianqian Liu, PhD^3*, Joel Michalek, PhD^3* and Adolfo Enrique Diaz Duque, MD⁴

¹University of Texas Health and Science Center at San Antonio, San Antonio, TX
²University of Texas Health San Antonio MD Anderson Cancer Center, San Antonio, TX
³Department of Population Health Sciences, University of Texas Health-San Antonio, San Antonio, TX
⁴MD Anderson, University of Texas San Antonio, San Antonio, TX

Sara Rossetti, MD^1*, Sidsel Jacobsen Juul, MD^2*, Frank Eriksson, PhD^3*, Peder Emil Warming, MD^4*, Charlotte Glinge, MD, PhD^5*, Tarec Christoffer Christoffer El-Galaly, MD, DSc^6,7,8, Jacob Haaber Christensen, MD, PhD^9*, Peter Kamper, MD, PhD^10*, Peter de Nully Brown, MD, PhD¹¹, Maja Maraldo, MD, PhD^12*, Jacob Tfelt-Hansen, Professor, MD, DMSC^13,14* and Martin Hutchings, MD, PhD^1,15*

¹Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
²Department of Clinical Oncology,, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
³Section of Biostatistics, University of Copenhagen, Copenhagen, Denmark
⁴The Heart Center, University Hospital Copenhagen, Rigshospitalet, Copenhagen, Denmark
⁵The Heart Center, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark
⁶Department of Hematology, Odense University Hospital, Odense, Denmark
⁷Department of Hematology, Aalborg University Hospital, Aalborg, Denmark
⁸Department of Medicine Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden
⁹Department of Hematology, Odense University Hospital, Odense C., DNK
¹⁰Department of Hematology, Aarhus University Hospital, Aarhus, Denmark
¹¹Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
¹²Department of Cliical Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
¹³The Heart Center, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
¹⁴Department og Forensic Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
¹⁵Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark

Lianna J. Marks, MD¹, Yiwang Zhou, PhD^2*, Ying Zheng^2*, Angela Feraco, MD, MSc³, Alison M. Friedmann, MD, MSC^4*, Howard J. Weinstein, MD^4*, Michael P. Link, MD¹ and Jamie E. Flerlage, MD, MS⁵

¹Department of Pediatrics, Division of Pediatric Hematology and Oncology, Stanford University, Palo Alto, CA
²Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN
³Boston Children's Hospital/Dana Farber, Boston, MA
⁴Massachusetts General Hospital for Children, Boston, MA
⁵Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN

Vittorio Ruggero Zilioli^1*, Emanuele Cencini, MD^2*, Sonya De Lorenzo^3*, Luca Pezzullo^4*, Michele Merli^5*, Flavia Rivellini^3*, Cristina Muzi, MD^6*, Emiliano Barbieri^7*, Luigi Marcheselli^8* and Stefano Luminari, MD⁹

¹Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milano, IT-MI, Italy
²Hematology, Azienda Ospedaliera Universitaria Senese & University of Siena, Siena, Italy
³U.O.C. Ematologia e T.M.O., AORN "S.G. Moscati", Avellino, Italy
⁴U.O.C. di Ematologia con Trapianto di Midollo Osseo, A.U.O. "San Giovanni di Dio e Ruggi D'Aragona", Salerno, Italy
⁵Ospedale di Circolo e Fondazione Macchi, Varese, Italy
⁶Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
⁷Hematology Unit, Arcispedale S. Maria Nuova, Azienda Unità Sanitaria Locale - IRCCS, Reggio Emilia, Italy
⁸Fondazione Italiana Linfomi, Clinical Trial Office, Modena, Italy
⁹Hematology Unit, Arcispedale S. Maria Nuova, Azienda Unità Sanitaria Locale - IRCCS, University of Modena and Reggio Emilia, Reggio Emilia, Italy

Zachary Braunstein, MD¹, Allyson Waller, PharmD^2*, Emily Dotson, PharmD^3*, Eric McLaughlin, MS^4*, Walter Hanel, MD, PhD⁵, John C Reneau, MD, PhD⁵, Daniel Addison, MD^6*, Pierluigi Porcu, MD⁷ and Jonathan E. Brammer, MD⁵

¹The James Cancer Hospital at The Ohio State University Wexner Medical Center, Columbus, OH
²Department of Pharmacy, The Ohio State University Comprehensive Cancer Center, Columbus, OH
³The Ohio State University Wexner Medical Center, Columbus, OH
⁴Center for Biostatistics, The Ohio State University, Columbus, OH
⁵The James Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH
⁶Department of Cardiology, The Ohio State University Wexner Medical Center, Columbus, OH
⁷Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA

Maria Huguet, MD^1*, Aleix Méndez^2*, Blanca Sanchez-Gonzalez^3*, Mariana Bastos-Oreiro, MD^4*, Ramon Garcia-Sanz, MD, PhD^5*, Samuel Romero, MD^6*, María-Jesús Vidal-Manceñido^7*, Antonio Gutiérrez, MD, PhD^8*, Paola Villafuerte Gutierrez, MD^9*, Ana Garcia Noblejas, MD^10*, Gustavo Tapia^11*, Juan-Manuel Sancho, MD, PhD^12*, Josep-Maria Ribera, MD, PhD¹³ and José-Tomás Navarro^2*

¹Hematology Department, ICO Badalona, Germans Trias i Pujol University Hospital. Universitat Autònoma de Barcelona. Josep Carreras Leukemia Research Institute, Barcelona, AL, Spain
²Hematology Department, ICO Badalona, Germans Trias i Pujol University Hospital. Universitat Autònoma de Barcelona. Josep Carreras Leukemia Research Institute, Badalona, Spain
³Hematology Department, Hospital del Mar, Barcelona, Spain
⁴Hematology Department, Hospital General Gregorio Marañon, Madrid, Spain
⁵University Hospital of Salamanca, Salamanca, Spain
⁶Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain
⁷Hematology Department, Hospital de León, León, Spain
⁸Hematology Department, Hospital Universitario Son Espases, Palma de Mallorca, Spain
⁹Hematology Department, Hospital Universitario Principe de Asturias, Madrid, ESP
¹⁰Hematology Department, Hospital Universitario La Princesa, Madrid, Spain
¹¹Department of Pathology, Germans Trias i Pujol University Hospital, Universitat Autònoma de Barcelona, Badalona, Spain
¹²Hematology Department, ICO Badalona, Germans Trias i Pujol University Hospital. Universitat Autònoma de Barcelona. Josep Carreras Leukemia Research Institute, Barcelona, Spain
¹³ICO-Hospital Germans Trias i Pujol, Institut de Recerca contra la Leucèmia Josep Carreras (IJC), Universitat Autònoma de Barcelona, Badalona, Spain

Rasmus Rask Kragh Jørgensen, MSc^1,2*, Sandra Eloranta^3*, Jacob Haaber Christensen, MD, PhD^4*, Martin Hutchings, MD, PhD^5,6*, Rasmus Bo Dahl-Soerensen^7*, Peter Kamper, MD, PhD^8*, Andrew M Evens, DO, MBA, MMSc⁹, Matthew J. Maurer, DSc¹⁰, Susan K Parsons, MD, MRCP¹¹, Angie Mae Rodday, PhD, MS¹², Jenica Upshaw, MD^13*, Tarec Christoffer Christoffer El-Galaly, MD, DSc^14,15,16 and Lasse Hjort Jakobsen, MSc, PhD^17,18*

¹Department of Hematology, Aalborg University hospital, Aalborg, Denmark
²Department of Clinical Medicine, Aalborg University hospital, Aalborg, Denmark
³Department of Medicine Solna, Karolinska Institutet, Stockholm, SWE
⁴Department of Hematology, Odense University Hospital, Odense C., DNK
⁵Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
⁶Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
⁷Zealand University Hospital, Roskilde, DNK
⁸Department of Hematology, Aarhus University Hospital, Aarhus, Denmark
⁹Division of Blood Disorders, Rutgers Cancer Institute New Jersey, New Brunswick, NJ
¹⁰Department of Health Sciences Research, Mayo Clinic, Rochester, MN
¹¹The Center for Health Solutions, Tufts Medical Center, Boston, MA
¹²Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA
¹³Cardio-Oncology Program, Tufts Medical Center, Boston, MA
¹⁴Department of Hematology, Aalborg University Hospital, Aalborg, Denmark
¹⁵Department of Hematology, Odense University Hospital, Odense, Denmark
¹⁶Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
¹⁷Department of Mathematical Sciences, Aalborg University, Aalborg, Denmark
¹⁸Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark

Paul J Bröckelmann, MD^1*, Ina Bühnen^2*, Peter Herhaus, MD^3*, Julia Meissner, MD^4*, Karolin Trautmann-Grill, MD^5*, Horst Müller, PhD^1*, Michael Fuchs, MD^1*, Bastian von Tresckow, MD⁶, Peter Borchmann⁷, Andreas Engert, MD^1* and Karolin Behringer, MD^1*

¹Department I of Internal Medicine, German Hodgkin Study Group (GHSG), University Hospital of Cologne, Cologne, Germany
²Department I of Internal Medicine, German Hodgkin Study Group (GHSG), University Hospital Cologne, Cologne, Germany
³Clinic and Policlinic for Internal Medicine III, Technical University of Munich, School of Medicine, Klinikum rechts der Isar, Munich, Germany
⁴Medicine V, University Hospital of Heidelberg, Heidelberg, Germany
⁵Medical Clinic I, University Hospital Carl Gustav Carus, Dresden, Germany
⁶Department of Hematology and Stem Cell Transplantation, West German Cancer Center Essen, Essen, Germany
⁷Department I of Internal Medicine, German Hodgkin Study Group (GHSG), University Hospital of Cologne, Koeln, Germany